192 related articles for article (PubMed ID: 34475993)
1. CMTM3 Overexpression Predicts Poor Survival and Promotes Proliferation and Migration in Pancreatic Cancer.
Zhou Z; Ma Z; Li Z; Zhuang H; Liu C; Gong Y; Huang S; Zhang C; Hou B
J Cancer; 2021; 12(19):5797-5806. PubMed ID: 34475993
[No Abstract] [Full Text] [Related]
2. miR-135b-5p promotes gastric cancer progression by targeting CMTM3.
Lu M; Huang Y; Sun W; Li P; Li L; Li L
Int J Oncol; 2018 Feb; 52(2):589-598. PubMed ID: 29345297
[TBL] [Abstract][Full Text] [Related]
3. CMTM3 suppresses chordoma progress through EGFR/STAT3 regulated EMT and TP53 signaling pathway.
Yuan W; Wei F; Ouyang H; Ren X; Hang J; Mo X; Liu Z
Cancer Cell Int; 2021 Sep; 21(1):510. PubMed ID: 34560882
[TBL] [Abstract][Full Text] [Related]
4. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
Zhang H; Zhang J; Nan X; Li X; Qu J; Hong Y; Sun L; Chen Y; Li T
Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
[TBL] [Abstract][Full Text] [Related]
5. CMTM3 is frequently reduced in clear cell renal cell carcinoma and exhibits tumor suppressor activities.
Xie J; Yuan Y; Liu Z; Xiao Y; Zhang X; Qin C; Sheng Z; Xu T; Wang X
Clin Transl Oncol; 2014 Apr; 16(4):402-9. PubMed ID: 23907292
[TBL] [Abstract][Full Text] [Related]
6. CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells.
Hu F; Yuan W; Wang X; Sheng Z; Yuan Y; Qin C; He C; Xu T
Clin Transl Oncol; 2015 Aug; 17(8):632-9. PubMed ID: 25990505
[TBL] [Abstract][Full Text] [Related]
7. [Knockdown of CMTM3 promotes migration and invasion of PC3 cell in vitro].
Hu FZ; Yuan WQ; Wang XL; Qin CP; Sheng ZZ; DU YQ; Yin HQ; Xu T
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):594-597. PubMed ID: 29263495
[TBL] [Abstract][Full Text] [Related]
8. [Knockdown of CMTM3 promotes migration and invasion of PC3 cell in vitro].
Hu FZ; Yuan WQ; Wang XL; Qin CP; Sheng ZZ; DU YQ; Yin HQ; Xu T
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):594-7. PubMed ID: 27538134
[TBL] [Abstract][Full Text] [Related]
9. CKLF-Like MARVEL Transmembrane Domain-Containing Member 3 (CMTM3) Inhibits the Proliferation and Tumorigenisis in Hepatocellular Carcinoma Cells.
Li W; Zhang S
Oncol Res; 2017 Jan; 25(2):285-293. PubMed ID: 27629543
[TBL] [Abstract][Full Text] [Related]
10. CMTM3 inhibits cell migration and invasion and correlates with favorable prognosis in gastric cancer.
Su Y; Lin Y; Zhang L; Liu B; Yuan W; Mo X; Wang X; Li H; Xing X; Cheng X; Dong B; Hu Y; Du H; Zhu Y; Ding N; Li J; Liu W; Ma Y; Qiu X; Ji J; Han W
Cancer Sci; 2014 Jan; 105(1):26-34. PubMed ID: 24131472
[TBL] [Abstract][Full Text] [Related]
11. New prognostic biomarker
Li S; Gao P; Dai X; Ye L; Wang Z; Cheng H
Ann Transl Med; 2022 Feb; 10(4):206. PubMed ID: 35280380
[TBL] [Abstract][Full Text] [Related]
12. Chemokine-like factor-like MARVEL transmembrane domain-containing 3 expression is associated with a favorable prognosis in esophageal squamous cell carcinoma.
Han T; Shu T; Dong S; Li P; Li W; Liu D; Qi R; Zhang S; Zhang L
Oncol Lett; 2017 May; 13(5):2982-2988. PubMed ID: 28521405
[TBL] [Abstract][Full Text] [Related]
13. CMTM3 decreases EGFR expression and EGF-mediated tumorigenicity by promoting Rab5 activity in gastric cancer.
Yuan W; Liu B; Wang X; Li T; Xue H; Mo X; Yang S; Ding S; Han W
Cancer Lett; 2017 Feb; 386():77-86. PubMed ID: 27867015
[TBL] [Abstract][Full Text] [Related]
14. CMTM3 protects the gastric epithelial cells from apoptosis and promotes IL-8 by stabilizing NEMO during Helicobacter pylori infection.
Zhang J; Ning J; Fu W; Shi Y; Zhang J; Ding S
Gut Pathog; 2023 Feb; 15(1):6. PubMed ID: 36782312
[TBL] [Abstract][Full Text] [Related]
15. LEM domain containing 1 promotes pancreatic cancer growth and metastasis by p53 and mTORC1 signaling pathway.
Cao X; Yao N; Zhao Z; Fu Y; Hu Y; Zhu P; Shi W; Tang L
Bioengineered; 2022 Mar; 13(3):7771-7784. PubMed ID: 35286235
[TBL] [Abstract][Full Text] [Related]
16. EZR promotes pancreatic cancer proliferation and metastasis by activating FAK/AKT signaling pathway.
Xu J; Zhang W
Cancer Cell Int; 2021 Oct; 21(1):521. PubMed ID: 34627255
[TBL] [Abstract][Full Text] [Related]
17. CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions.
Chrifi I; Louzao-Martinez L; Brandt M; van Dijk CGM; Burgisser P; Zhu C; Kros JM; Duncker DJ; Cheng C
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1098-1114. PubMed ID: 28428220
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of CMTM3 promotes metastasis of gastric cancer via the STAT3/Twist1/EMT signaling pathway.
Yuan W; Li T; Mo X; Wang X; Liu B; Wang W; Su Y; Xu L; Han W
Oncotarget; 2016 May; 7(20):29507-19. PubMed ID: 27121055
[TBL] [Abstract][Full Text] [Related]
19. CMTM3 as a Potential New Immune Checkpoint Regulator.
Shen Q; Cong Z; Zhou Y; Teng Y; Gao J; Tang W
J Oncol; 2022; 2022():2103515. PubMed ID: 36245970
[TBL] [Abstract][Full Text] [Related]
20. CYP26A1 Is a Novel Cancer Biomarker of Pancreatic Carcinoma: Evidence from Integration Analysis and
Yu Y; Wang Y; Zou Y; Yu Y
Dis Markers; 2022; 2022():5286820. PubMed ID: 35707714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
